Italian Researchers Identify Common Susceptibility Genes in COVID-19 Patients
The researchers looked to identify genetic differences with clinical outcomes. Using that study form, for each patient, the team identified an average of three disease-causing mutations involved in COVID-19 susceptibility.
8 Companion Diagnostic Developers Making a Mark
If companion diagnostics (CDx) were people, they would be old enough to drink. The first CDx won FDA approval in 1998, when Dako Denmark...
10 Countries in 100K Genome Club
These ten governments have committed funding for projects that will sequence a minimum of 100,000 citizens to spur genomic medicine
10 Liquid Biopsy Companies in the Money
10 privately-held diagnostics developers primarily focused on liquid biopsy tests, ranked by total money raised from venture capital firms.
Abbott Launching ID NOW COVID-19 Tests, Offering Positive Results in Five Minutes
Company expects to deliver 50,000 tests per day of the rapid, instrument-based, isothermal system designed for qualitative detection of infectious diseases.
Mining the Microbiome: Microbiome startups are proliferating, exploring new markets, and colonizing diverse therapeutic...
It would be hard to find an area of health where the microbiome has not been implicated as a major player. The microbiome is...
UnitedHealthcare To Cover Genetic Testing for Precision Medicine in Depression, Anxiety
The nation’s largest private health insurer, UnitedHealthcare, announced August 1 that it will cover testing that will allow physicians to match their patients to...
New Study Suggests COVID-19 Reinfection Unlikely
The study used four adult Chinese rhesus macaques and found that those monkeys that had been re-exposed to SARS-CoV-2, like the unexposed control monkey, showed no recurrence of COVID-19.
Cepheid, Sherlock to Develop Coronavirus Test, Part of Broader MDx Collaboration
The companies will partner on a proof-of-concept project focused on detection of SARS-CoV-2 coronavirus as the first initiative of a broader collaboration focused on developing molecular diagnostic tests for infectious diseases and oncology.
COVID-19 Test Can Detect Infection in Less Than 45 Minutes
Researchers based at the Beaumont Health System in Michigan, have developed a test using a method known as Reverse Transcription Loop-Mediated Isothermal Amplification or RT-LAMP, that does not require the repeated heating cycles of PCR.
